autologous ex vivo expanded NK cells (Nationwide Children's Hospital)

N/A

Report date: 2025/01/26 19:35:53

Base Information

Drug Nameautologous ex vivo expanded NK cells (Nationwide Children's Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsOligodendrogliomaGliosarcomaGlioblastoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesNationwide Children'S Hospital
Inactive CompaniesN/A
Active IndicationsOligodendrogliomaGliosarcomaGlioblastoma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A